Atossa Genetics, Inc. announced that Janet Rose Rea, M.S.P.H., has joined the company as VP Regulatory Affairs and Quality, effective October 12, 2015. Ms. Rea has nearly 35 years of industry leadership experience in regulatory affairs and quality.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.61 USD | 0.00% | -4.73% | +82.95% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+82.95% | 202M | |
+33.37% | 49.46B | |
+1.55% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.57% | 26.61B | |
-21.00% | 18.64B | |
+7.36% | 13.16B | |
+28.30% | 12.55B | |
+23.80% | 12.1B |
- Stock Market
- Equities
- ATOS Stock
- News Atossa Therapeutics, Inc.
- Atossa Genetics, Inc. Appoints Janet Rose Rea as VP Regulatory Affairs and Quality